Review
Version 1
Preserved in Portico This version is not peer-reviewed
Advances in Transdermal Drug Delivery Systems: a Bibliometric and Patent Analysis
Version 1
: Received: 5 December 2023 / Approved: 6 December 2023 / Online: 6 December 2023 (12:17:09 CET)
A peer-reviewed article of this Preprint also exists.
Cammarano, A.; Dello Iacono, S.; Meglio, C.; Nicolais, L. Advances in Transdermal Drug Delivery Systems: A Bibliometric and Patent Analysis. Pharmaceutics 2023, 15, 2762. Cammarano, A.; Dello Iacono, S.; Meglio, C.; Nicolais, L. Advances in Transdermal Drug Delivery Systems: A Bibliometric and Patent Analysis. Pharmaceutics 2023, 15, 2762.
Abstract
Transdermal drug delivery systems have become an intriguing research topic in healthcare technology and one of the most frequently developed pharmaceutical products in the global market. In recent years, researchers and pharmaceutical companies have made significant progress in developing new solutions in the field. This study sheds light on current trends, collaboration patterns, research hotspots, and emerging frontiers of transdermal drug delivery. Herein, a bib-liometric and patent analysis of data recovered from Scopus and The Lens databases, respectively, is reported over the last 20 years. From 2000 to 2022, the annual global publications increased from 131 in 2000 to 659 in 2022. Researchers in the United States, China, and India produced the highest number of publications. Likewise, most patent applications have been filed in the USA, China, and Europe. The recovered patents are 7,275, grouped into 2,997 patent families, of which 314 were granted. This study could support the work of decision-makers, scientific managers, or scientists to create new business opportunities or save money, time, and intellectual capital, thus, defining when a research or technology project should be a priority or not.
Keywords
Transdermal drug delivery; patent analysis; bibliometric analysis; transdermal administration; controlled release
Subject
Medicine and Pharmacology, Other
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment